Bulletin
Investor Alert

Alexion Pharmaceuticals Inc.

NASDAQ: ALXN

GO

Set Alerts

Find a Broker

Join TD Ameritrade

Market Index

Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Alexion Pharmaceuticals Inc.

After Hours

ALXN
/quotes/zigman/59581/composite

$

125.60

Change

+0.01 +0.0080%

Volume

Volume 97,170

Nov 29, 2016, 7:29 p.m.

Quotes are delayed by 20 min

/quotes/zigman/59581/composite

Today's close

$ 119.38

$ 125.59

Change

+6.21 +5.20%

Day low

Day high

$118.58

$127.55

Open
Open: 121.00

52 week low

52 week high

$110.56

$193.45

Open

Market cap

$26.77B

Average volume

2.30M

P/E ratio

77.05

Rev. per Employee

$997,142

EPS

1.63

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/alxn

MarketWatch News on ALXN

  4. Alexion Pharmaceuticals started at buy with $164 stock price target at Deutsche Bank

    1:24 p.m. Nov. 3, 2016

    - Tomi Kilgore

  5. 15 third-quarter earnings winners include Netflix, Amazon and Adobe

    12:22 p.m. Oct. 31, 2016

    - Philip van Doorn

  6. Stock market ends lower on mixed earnings, defensive sector weakness

    3:23 p.m. Oct. 27, 2016

    - Wallace Witkowski

  7. Alexion Pharma raises revenue outlook

    7:18 a.m. Oct. 27, 2016

    - MarketWatch.com

  8. Alexion Pharmaceuticals started at neutral with $132 stock price target at Wedbush Securities

    6:52 a.m. Sept. 23, 2016

    - Tomi Kilgore

  9. Alexion Pharmaceuticals started at underperform with $82 stock price target at FBR & Co.

    8:54 a.m. Sept. 15, 2016

    - Tomi Kilgore

  10. Alexion Pharmaceuticals started at outperform with $188 stock price target at RBC Capital

    6:46 a.m. July 13, 2016

    - Tomi Kilgore

  11. Alexion Pharmaceuticals upgraded to outperform from neutral at Credit Suisse

    10:55 a.m. July 11, 2016

    - Tomi Kilgore

  12. 10 stock winners, 10 losers in the first half of 2016

    6:49 a.m. July 4, 2016

    - Philip van Doorn

  13. Biotech stocks are in for more election trouble on drug pricing

    7:57 a.m. June 20, 2016

    - Michael Brush

  14. Alexion shares fall after drug study fails to reach main goal

    3:37 p.m. June 6, 2016

    - Wallace Witkowski

  15. Alexion Pharma shares unhalted, fall 7% on drug study results

    3:31 p.m. June 6, 2016

    - Wallace Witkowski

  16. Alexion Pharmaceuticals stock halted for pending news

    3:03 p.m. June 6, 2016

    - Jeremy C. Owens

  18. Alexion Pharmaceuticals upgraded to outperform from market perform from BMO Capital

    9:54 a.m. April 29, 2016

    - Tomi Kilgore

  20. These companies get the most bang for the buck with their buybacks

    6:18 a.m. March 18, 2016

    - Wallace Witkowski

  21. Loading more headlines...
Get more info »

Where does this data come from?

Analyst Estimates »
A data point based on hundreds of brokers buy, sell and hold rating.

Sentiment on ALXN

Analyst Ratings

/news/nonmarketwatch/company/us/alxn

Other News on ALXN

  1. Why Thor Industries, Alexion Pharmaceuticals, and Berry Plastics Jumped Today

    5:19 p.m. Today

    - Motley Fool

  2. U.S. Stocks Edge Higher

    4:09 p.m. Today

    - The Wall Street Journal Interactive Edition

  3. Barclays likes Alexion, sees 25% upside

    1:21 p.m. Today

    - Seeking Alpha

  4. Healthcare Stocks Help Nasdaq Reach New Heights

    12:31 p.m. Today

    - TheStreet.com

  6. Barclays Downgrades 5 Biopharma Stocks, Upgrades Pfizer And Alexion

    9:39 a.m. Today

    - benzinga.com

  7. Analysts' Actions -- Goldman Sachs, Johnson & Johnson, Pfizer and More

    8:16 a.m. Today

    - TheStreet.com

  8. Benzinga's Top Upgrades

    7:49 a.m. Today

    - benzinga.com

  9. Short Sellers Grow More Aggressive on Major Biotechs

    6:52 a.m. Nov. 28, 2016

    - 247WallSt.com

  10. The Problem With Lilly Is the Problem With Pharma

    3:00 p.m. Nov. 23, 2016

    - The Wall Street Journal Interactive Edition

  11. Competitive Results May Affect Omeros Corporation

    7:49 a.m. Nov. 23, 2016

    - Seeking Alpha

  14. 3 Beaten-Down Biotech Stocks You Can Buy Right Now

    8:23 a.m. Nov. 22, 2016

    - Motley Fool

  15. SD-809 Could Be a Strong Growth Driver for Teva Pharmaceutical

    1:36 p.m. Nov. 21, 2016

    - MarketRealist.com

  16. 10 Stocks That Rallied Four Days, Then Sold Off On Friday

    11:08 a.m. Nov. 21, 2016

    - benzinga.com

  17. BMO Sets Outperform Rating, $26 Target On Ra Pharmaceuticals

    8:16 a.m. Nov. 21, 2016

    - benzinga.com

  18. Alexion, JetBlue, Sothebys: Fast Money Picks For November 21

    5:53 a.m. Nov. 21, 2016

    - benzinga.com

  21. Loading more headlines...
/news/pressrelease/company/us/alxn

Press Releases on ALXN

  3. Alexion to Present at the Citi 2016 Global Healthcare Conference

    10:00 a.m. Today

    - BusinessWire - BZX

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto CREDIT CARDS
5 yr CD
1.2%
2 yr CD
0.8%
1 yr CD
0.6%
MMA $10K+
0.3%
MMA $50K+
0.4%
MMA Savings
0.3%
MMA Savings Jumbo
0.4%

National averages from Bankrate.com

You Don’t Need Another Credit Card, You Need A Better One.
Avg. APR Last Week 6 Months
Low Interest 12.00% 12.00% 11.96%
Business 13.12% 13.12% 13.12%
Student 13.42% 13.42% 13.42%
Balance Transfer 14.41% 14.41% 14.39%
Airline 15.13% 15.13% 15.17%
Reward 15.24% 15.24% 15.30%
Cash Back 15.33% 15.33% 15.30%
Instant Approval 17.86% 17.86% 18.04%
Bad Credit 22.86% 22.86% 22.56%
Source:CreditCards.com
Trending Tickers
  • /quotes/zigman/78102759/composite NTNX+2.25%
  • /quotes/zigman/413712/composite USO-3.64%
  • /quotes/zigman/4194817/composite SCO+6.99%
  • /quotes/zigman/14634168/composite TXMD-15.46%
  • /quotes/zigman/9588578/composite SPLK-0.07%
X
Powered by StockTwits
Link to MarketWatch's Slice.